How many employees does Surepharm Topco Limited have?

Surepharm Topco Limited reported an average of 120 employees in the year to 31 Oct 2023.

Company No. 13487288

Surepharm Topco LimitedDissolved

Q: Is Surepharm Topco Limited profitable?

No — Surepharm Topco Limited reported a loss of £53k in the year to 31 Oct 2023.

Surepharm Topco Limited made a £53k loss in the year to 31 Oct 2023 (revenue not disclosed).

Surepharm Topco Limited reported a loss of £53k in the year to 31 Oct 2023; its revenue was not disclosed. It had 120 employees. We hold 2 years of its filed accounts. It is no longer on the Companies House register.

Profit only

This company is no longer on the Companies House register. Figures are from its last filed accounts.

Status: Dissolved

Last filed accounts · year to 31 Oct 2023

Key figures

Independent

Revenue

—

Not disclosed in filing

Profit

−£53k

Growth —

Profit margin

—

Employees

120

Change —

Profit / employee

−£441

Profitable streak

0yrs

Consecutive profitable years in our data

This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Oct 2022	31 Oct 2023
Disclosure	Profit only	Profit only
Profit & loss
Revenue (turnover)	—	—
Profit after tax	−£2.3m	−£53k
Profit (best available)	−£2.3m	−£53k
Employees (average)	137	120
Ratios
Profit margin	—	—
Profit per employee	−£16.8k	−£441
Balance sheet — indirect signals, not revenue
Net assets	£195k	£878
Fixed assets	£1	£1
Debtors	£0	£0
Deferred income	£0	£0
Source	FullAccounts · bulk data Oct 2024	FullAccounts · bulk data Oct 2024

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: −£441; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now £878
Cash at bank: —; Now —
Headcount: —; Now 120
Deferred income: —; Now £0
Fixed assets: —; Now £1

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Subsidiaries (1)

Surepharm Bidco LimitedLiquidationRev. £0 · Profit −£438k

From the Persons with Significant Control register (corporate controllers only).

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Oct 2023 (profit −£53k), from the Companies House accounts bulk data published Oct 2024. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.